Phathom Pharmaceuticals, Inc. - 8-K Filing
FDA establishes public docket to solicit comments on VOQUEZNA (vonoprazan) regulatory exclusivity litigation involving BDR Pharmaceuticals. (Items: 8.01 Other Events)
FDA establishes public docket to solicit comments on VOQUEZNA (vonoprazan) regulatory exclusivity litigation involving BDR Pharmaceuticals. (Items: 8.01 Other Events)